The connection between NAD⁺ and female hormones is one of the most important yet least discussed findings in longevity research. Here's what it means for your cycle and perimenopause, and why the symptoms most women accept as normal have a cellular explanation that no one has ever given them.
Women experiencing worsening PMS, a luteal phase that becomes more difficult each year, or perimenopausal symptoms starting earlier than expected usually hear one of two explanations: it's hormonal. Or it's stress.
Both answers fall short. The hormonal explanation is partly true but misses a crucial level: the cellular. The stress explanation is almost always wrong about the cause; the only thing that's right is that something is out of balance.
What neither answer explains: why hormonal regulation becomes less efficient with age. Why the same hormonal fluctuations that were manageable at 28 become debilitating at 38. And what is happening in the cell that causes this.
NAD⁺ is the missing piece of this explanation. Its decline doesn't just affect energy and sleep. It directly impacts the enzymatic processes that produce and regulate sex hormones.
This means: As NAD⁺ levels decline in the 30s and 40s, the hormonal system loses its cellular support, precisely at a time when hormone levels are shifting anyway. Both processes reinforce each other. And the result is what women are usually only told to cope with, instead of understanding it.
The direct connection between NAD⁺ and progesterone
The enzyme that converts pregnenolone to progesterone is called 3β-hydroxysteroid dehydrogenase. It cannot function without NAD⁺ as a cofactor.
This is not an indirect or subordinate relationship. NAD⁺ is structurally necessary for this enzyme to work. As NAD⁺ levels decrease, so does the enzyme's ability to efficiently produce progesterone.
Progesterone is the dominant hormone of the luteal phase, the second half of the menstrual cycle. It maintains the uterine lining, regulates mood, supports sleep quality in the second half of the month, and dampens the inflammatory response behind cramps and PMS symptoms.
This means: The slump in the luteal phase that many women experience—unstable mood, disturbed sleep, energy drop, worsening PMS—is not purely a hormonal event. At least not in the sense that it can be resolved solely at the hormonal level. Part of the problem is that the cells producing progesterone simply lack the NAD⁺ to do so efficiently.
Restoring NAD⁺ does not replace declining hormones. But it restores the cellular conditions under which these hormones are produced. And that is a fundamentally different approach from anything found in the usual discussion about hormone health.
Why perimenopause hits harder than it should
Perimenopause can begin as early as 35. Menopause itself occurs on average between 51 and 52 years of age. Throughout this entire period, NAD⁺ levels simultaneously decline.
This means: The hormonal system loses its fundamental hormones, and the cells that support these hormones simultaneously lose their most important energy source.
The hormonal fluctuations of perimenopause are destabilizing on their own. Estrogen and progesterone levels begin to fluctuate unpredictably. Sleep is disturbed. Mood becomes more unstable. And the body's stress response changes.
When these fluctuations coincide with declining NAD⁺ levels, the cellular systems that would otherwise buffer them are also weakened. This is a key reason why perimenopause is usually experienced more severely than expected, and why the usual reassurance that "it's all normal" rarely matches what women actually go through.
What human research shows
The most significant human NMN study to date was specifically conducted with postmenopausal women. Not because this group was easy to recruit, but because both hormonal and NAD⁺ decline are most advanced in them, and the metabolic consequences of both are best measurable.
Yoshino et al. published in Science in 2021 that daily NMN intake over ten weeks significantly improved insulin sensitivity in muscles. Additionally, the activity of genes involved in muscle tissue remodeling increased.
Insulin sensitivity in muscle tissue is directly relevant to hormonal health. Insulin resistance and impaired regulation of sex hormones are closely linked, especially in peri- and postmenopause.
There are still few studies directly measuring the effect of NMN on progesterone levels, cycle regularity, or luteal phase symptoms in humans. This should be honestly stated.
The mechanism of action is documented, and metabolic data from human studies are consistent with what biology would expect. Specific hormone research in women is only just beginning. This also reflects the same research gap that has left women's health underfunded for decades.
What NMN does not do
NMN is not a hormone replacement and does not act like one. It does not directly raise estrogen or progesterone levels. And it does not correct a clinical hormone deficiency.
Women with diagnosed hormonal conditions—PCOS, endometriosis, premature ovarian insufficiency—should not consider NMN as a substitute for medical treatment or medically indicated hormone therapy.
What NMN does achieve is different: It restores the cellular energy environment in which hormonal processes occur. This is an effective approach, but different from hormone therapy.
This distinction is important to manage expectations and to ensure NMN is used for what it is: a cellular measure that supports hormone function, and not a replacement for hormones themselves.
What women who consistently take NMN report
Women who take NMN for three months or longer and track their cycle predominantly report the same: the second half of the month becomes noticeably easier. Usually from the first to second month.
The luteal phase does not disappear. Hormonal fluctuations still occur. But it no longer feels like having to meet the same demands with a fraction of the fuel.
Energy remains more consistent throughout the month. Sleep in the second half of the cycle improves. And PMS symptoms, which had been worsening year after year, begin to stabilize.
None of this can be promised on a fixed schedule, and individual differences are real. But the pattern is so consistent across women's reports that it reflects biology, not coincidence.